Clinical Trials Directory

Trials / Completed

CompletedNCT04857918

Assessing the Feasibility and Acceptability of a Social Identity Informed Virtual Running Group Program

The UBC Socializing Together While Running InDEpendently (STRIDE) Pilot Trial: A Social Identity Informed Virtual Running Group Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The STRIDE Pilot Trial is a randomized controlled pilot trial that will utilize social identity informed virtual running groups to support underactive undergraduate students' well-being and exercise behaviour. The main outcomes of this study are to determine whether the intervention is feasible and acceptable to conduct as a full-scale efficacy trial. Secondary outcomes of interest include changes in participants' exercise identity, exercise behaviour, perceived social support, and well-being. Participants' perceived social identification with their running group will also be assessed at the end of the study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVirtual running group programThe intervention will include an eight-week virtual running group program hosted on online platforms such as Zoom and the fitness application Strava. Participants will be placed in running groups of 6 people, and each running group will have the collective goal to run/walk the distance across the province of B.C., (940 km) and will meet weekly over Zoom to socialize and discuss running topics and their progress towards the group goal. Participants will receive a t-shirt with the STRIDE logo and a phone armband for carrying their smart phone during runs and walks.
BEHAVIORALAttention Control: Fitness Application StravaThe attention control condition will be instructed to record their exercise using the Strava application, and will be encouraged to participate in 150 minutes of moderate-to-vigorous exercise each week of the intervention.

Timeline

Start date
2021-04-23
Primary completion
2022-05-09
Completion
2022-05-09
First posted
2021-04-23
Last updated
2022-05-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04857918. Inclusion in this directory is not an endorsement.